44th ISICEM

P265

Gabriela Kroneislová

Limited treatment options for infections caused by carbapenem resistant enterobacterales. Is it necessary to also know the carbapenemase type?

P266

Aleksandr Burov

Impact of Pseudomonas aeruginosa antibiotic resistance on icu and hospital length of stay: an observational study

P267

Jelle Haitsma Mulier

A framework for outcome determination of nosocomial pneumonia treatment in critically ill patients

P268

Mike Greenberg

Burden and costs of 30-day hospital readmissions among survivors of hospitalization with severe community-acquired bacterial pneumonia in the United States, 2018-2022

P269

Sjoerd van der Bie

Characteristics and outcomes of ICU patients with severe acute respiratory infections (SARI): a comparison of respiratory syncytial virus, human metapneumovirus, influenza, and parainfluenza

P270

Jan Závora

Increasing incidence of anaerobic bacteria detected in samples from intra-abdominal infections in a surgical intensive care unit.

P271

Hilal Keklik

The impact of carbapenem-resistant gram-negative catheter infections on mortality

P272

Marco Goeijenbier

Impact of 2024 seasonal influenza surge on Dutch intensive care units: a descriptive cohort study of 32 Dutch hospitals

P273

Mayken Visser

Comprehensive antibody (binding) profiles in two commercial IVIg preparations targeting diverse pathogens

P274

Bárbara Sucena Rodrigues

Empiric antimicrobials in acute liver failure: a retrospective cohort study

P275

Rytis Mickus

Treatment with metronidazole is associated with clostridioides difficile infectious disease-related adverse outcomes

P276

Sara Travassos

Microbial profile and antibiotic resistance patterns in ventilator-associated pneumonia